Plasma cell dyscrasias (PCDs), like multiple myeloma, are hematologic disorders that lead to compromised immune responses, making vaccinations, particularly against influenza, less effective in patients with PCDs due to their altered immunity and the impacts of antimyeloma therapies.

Read More >https://multiplemyeloma.pocn.com/treatment/shivering-2-trial-shows-tandem-high-dose-influenza-vaccines-significantly-improve-protection-in-plasma-cell-dyscrasia-patients/